Biomarin Pharmaceutical Inc (BMRN) — Financial Flexibility Index
Biomarin Pharmaceutical Inc (BMRN) has a Financial Flexibility Index of 0.04x as of June 2026. Free cash flow of $196.93 Million (operating CF $168.11 Million minus capex $28.82 Million) represents 0% of total liabilities ($5.40 Billion). Check Biomarin Pharmaceutical Inc (BMRN) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Biomarin Pharmaceutical Inc Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Biomarin Pharmaceutical Inc across 28 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Biomarin Pharmaceutical Inc.
Annual Financial Flexibility Index for Biomarin Pharmaceutical Inc (1998–2025)
Year-by-year free cash flow to debt coverage for Biomarin Pharmaceutical Inc. Explore Biomarin Pharmaceutical Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.62x | $931.03 Million | $827.99 Million | $1.51 Billion | ▲ +22.7% |
| 2024 | 0.50x | $670.26 Million | $572.84 Million | $1.33 Billion | ▲ +256.7% |
| 2023 | 0.14x | $266.87 Million | $159.26 Million | $1.89 Billion | ▼ -15.7% |
| 2022 | 0.17x | $296.86 Million | $175.90 Million | $1.77 Billion | ▼ -31.5% |
| 2021 | 0.24x | $423.76 Million | $304.54 Million | $1.73 Billion | ▲ +91.2% |
| 2020 | 0.13x | $222.88 Million | $85.36 Million | $1.74 Billion | ▲ +3.8% |
| 2019 | 0.12x | $193.29 Million | $48.26 Million | $1.57 Billion | ▲ +9.2% |
| 2018 | 0.11x | $164.83 Million | $20.21 Million | $1.46 Billion | ▲ +8.2% |
| 2017 | 0.10x | $190.46 Million | $-8.76 Million | $1.82 Billion | ▲ +265.2% |
| 2016 | -0.06x | $-79.46 Million | $-227.84 Million | $1.26 Billion | ▼ -1507.6% |
| 2015 | 0.00x | $5.96 Million | $-221.69 Million | $1.33 Billion | ▼ -90.5% |
| 2014 | 0.05x | $45.30 Million | $-73.54 Million | $962.56 Million | ▲ +674.0% |
| 2013 | 0.01x | $5.49 Million | $-59.63 Million | $903.02 Million | ▼ -94.6% |
| 2012 | 0.11x | $62.18 Million | $17.61 Million | $552.58 Million | ▼ -65.3% |
| 2011 | 0.32x | $172.97 Million | $18.75 Million | $532.66 Million | ▲ +159.6% |
| 2010 | 0.13x | $68.21 Million | $18.75 Million | $545.37 Million | ▼ -58.1% |
| 2009 | 0.30x | $177.53 Million | $87.73 Million | $594.98 Million | ▲ +298.3% |
| 2008 | 0.07x | $47.19 Million | $-9.18 Million | $630.02 Million | ▲ +489.1% |
| 2007 | -0.02x | $-12.08 Million | $-34.49 Million | $627.55 Million | ▲ +73.9% |
| 2006 | -0.07x | $-25.51 Million | $-50.09 Million | $345.63 Million | ▲ +66.3% |
| 2005 | -0.22x | $-59.72 Million | $-62.68 Million | $272.76 Million | ▼ -60.5% |
| 2004 | -0.14x | $-41.07 Million | $-65.14 Million | $300.94 Million | ▲ +72.5% |
| 2003 | -0.50x | $-68.82 Million | $-74.80 Million | $138.49 Million | ▲ +87.7% |
| 2002 | -4.04x | $-48.73 Million | $-53.59 Million | $12.07 Million | ▼ -842.3% |
| 2001 | -0.43x | $-5.25 Million | $-23.07 Million | $12.26 Million | ▲ +67.5% |
| 2000 | -1.32x | $-9.14 Million | $-12.90 Million | $6.94 Million | ▼ -168.1% |
| 1999 | 1.93x | $10.00 Million | $-12.94 Million | $5.17 Million | ▲ +340.1% |
| 1998 | -0.81x | $-1.70 Million | $-8.10 Million | $2.11 Million | — |